CheckMate 017 and 057 studies of nivolumab vs docetaxel in patients with advanced NSCLC: 2-year-update and exploratory cytokine profile analyses Meeting Abstract
| Authors: | Eberhardt, W. E. E.; Borghaei, H.; Brahmer, J. R.; Horn, L.; Ready, N.; Steins, M.; Felip, E.; Paz-Ares, L. G.; Arrieta, O.; Barlesi, F.; Antonia, S. J.; Fayette, J.; Rizvi, N. A.; Crino, L.; Reck, M.; Hellmann, M.; Desai, K.; Li, A.; Healey, D.; Spigel, D. R. |
| Abstract Title: | CheckMate 017 and 057 studies of nivolumab vs docetaxel in patients with advanced NSCLC: 2-year-update and exploratory cytokine profile analyses |
| Meeting Title: | Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 39 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2016 Oct 14-18 |
| Meeting Location: | Leipzig, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2016-10-01 |
| Start Page: | 33 |
| Language: | English |
| ACCESSION: | WOS:000385691300080 |
| PROVIDER: | wos |
| DOI: | 10.1159/000449050 |
| Notes: | Meeting Abstract: V135 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
